Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026 and Aug 2026.
- Largest single sale: $1.8M (16,167 shares) of Dianthus Therapeutics, Inc. on Aug 10, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | SVP, General Counsel and Sec. | Sep 13, 2023 | Aug 14, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 13, 2026, Dianthus Therapeutics, Inc.: 15,000 shares acquired by exercising options. 1 filing: 1
- Aug 10, 2026, Dianthus Therapeutics, Inc.: sold 16,167 shares for $1.8M, under a disclosed plan; 16,167 shares acquired by exercising options. 1 filing: 1
- Aug 7, 2026, Dianthus Therapeutics, Inc.: sold 3,833 shares for $424K, under a disclosed plan; 3,833 shares acquired by exercising options. 1 filing: 1
- Jun 17, 2026, Dianthus Therapeutics, Inc.: sold 30,000 shares for $2.4M, under a disclosed plan; 30,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.